Pharmabiz36m
Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain
Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...
Pharmabiz1h
NIH-funded study finds contact lenses used to slow nearsightedness in youth have a lasting effect
Bethesda, Maryland Saturday, January 18, 2025, 17:00 Hrs [IST] ...
Pharmabiz2h
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US: Brussels, Belgium Saturday, January 18, 2025, 16:00 Hrs [ ...
Pharmabiz2h
Glenmark Life Sciences rebrands as Alivus Life Sciences
Glenmark Life Sciences, a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, announces its change of ...
Pharmabiz3h
Caris Life Sciences collaborates with Ontada to advance oncology research and the adoption of precision medicine
Caris Life Sciences collaborates with Ontada to advance oncology research and the adoption of precision medicine: Irving, Texas Saturday, January 18, 2025, 15:00 Hrs [IST] Caris L ...
Pharmabiz4h
UAE health ministry approves Biomerica’s Fortel PSA Screening Test to detect an early sign of prostate cancer
UAE health ministry approves Biomerica’s Fortel PSA Screening Test to detect an early sign of prostate cancer: Irvine, California Saturday, January 18, 2025, 14:00 Hrs [IST] Bio ...
Pharmabiz3h
China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer
China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer: Shanghai Saturday, January 18, 2025, 15:30 Hrs [IST] IM ...
Pharmabiz5h
Avicanna enters scientific and medical affairs collaboration with Vectura Fertin Pharma
Avicanna enters scientific and medical affairs collaboration with Vectura Fertin Pharma: Toronto Saturday, January 18, 2025, 13:30 Hrs [IST] Avicanna Inc., a commercial stage, int ...
Pharmabiz5h
In 2024 EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance
EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance: Amsterdam, The Netherlands Saturday, January 18, 2025, 13:00 Hrs [IST] European Me ...
Pharmabiz2d
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company, announces that the Scottish Medicines Consortium (SMC) has published recommendations that Agamree (vamorolone) is accepted for use ...
Pharmabiz6h
WHO launches US$ 1.5 billion Health Emergency Appeal to tackle unprecedented global health crises
WHO launches US$ 1.5 billion Health Emergency Appeal to tackle unprecedented global health crises: Geneva Saturday, January 18, 2025, 12:00 Hrs [IST] Conflict, climate change, epi ...
Pharmabiz7h
Boehringer Ingelheim’s phase III CONNEX clinical programme of iclepertin in schizophrenia fails to meet primary and key secondary endpoints
Ingelheim, Germany Saturday, January 18, 2025, 11:00 Hrs [IST] ...